Masterson et al., 2012 - Google Patents
Allostery and binding cooperativity of the catalytic subunit of protein kinase A by NMR spectroscopy and molecular dynamics simulationsMasterson et al., 2012
View PDF- Document ID
- 12925807745634571514
- Author
- Masterson L
- Cembran A
- Shi L
- Veglia G
- Publication year
- Publication venue
- Advances in protein chemistry and structural biology
External Links
Snippet
The catalytic subunit of cAMP-dependent protein kinase A (PKA-C) is an exquisite example of a single molecule allosteric enzyme, where classical and modern views of allosteric signaling merge. In this chapter, we describe the mapping of PKA-C conformational …
- 230000027455 binding 0 title abstract description 103
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Masterson et al. | Allostery and binding cooperativity of the catalytic subunit of protein kinase A by NMR spectroscopy and molecular dynamics simulations | |
Choy et al. | Conformational rigidity and protein dynamics at distinct timescales regulate PTP1B activity and allostery | |
Kang et al. | Structure and substrate recruitment of the human spindle checkpoint kinase Bub1 | |
Hünenberger et al. | Determinants of ligand binding to cAMP-dependent protein kinase | |
Shan et al. | Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization | |
Meng et al. | Tyrosine kinase activation and conformational flexibility: lessons from Src-family tyrosine kinases | |
Unbekandt et al. | A novel small-molecule MRCK inhibitor blocks cancer cell invasion | |
Homan et al. | Structural and functional analysis of G protein–coupled receptor kinase inhibition by paroxetine and a rationally designed analog | |
Bunney et al. | Crystal structure of the human, FIC-domain containing protein HYPE and implications for its functions | |
Dixon-Clarke et al. | Structure and inhibitor specificity of the PCTAIRE-family kinase CDK16 | |
Granovsky et al. | Raf kinase inhibitory protein function is regulated via a flexible pocket and novel phosphorylation-dependent mechanism | |
Vieweg et al. | PINK1-dependent phosphorylation of Serine111 within the SF3 motif of Rab GTPases impairs effector interactions and LRRK2-mediated phosphorylation at Threonine72 | |
Özden et al. | CaMKII binds both substrates and activators at the active site | |
Gógl et al. | Dynamic control of RSK complexes by phosphoswitch‐based regulation | |
Ruan et al. | Mechanistic insights into R776H mediated activation of epidermal growth factor receptor kinase | |
Xue et al. | X‐ray structural analysis of Tau‐Tubulin kinase 1 and its interactions with small molecular inhibitors | |
WO2015002860A1 (en) | Structure-based modeling and target-selectivity prediction | |
Kaltheuner et al. | Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation | |
Ivan et al. | Bifunctional ligands for inhibition of tight-binding protein–protein interactions | |
Lindenblatt et al. | Molecular plasticity of crystalline CK2α′ leads to KN2, a bivalent inhibitor of protein kinase CK2 with extraordinary selectivity | |
Arencibia et al. | An allosteric inhibitor scaffold targeting the PIF-pocket of atypical protein kinase C isoforms | |
Heimhalt et al. | Bipartite binding and partial inhibition links DEPTOR and mTOR in a mutually antagonistic embrace | |
Pflug et al. | Mutants of protein kinase A that mimic the ATP-binding site of Aurora kinase | |
González et al. | Characterization of p38α autophosphorylation inhibitors that target the non-canonical activation pathway | |
Raaf et al. | First inactive conformation of CK2α, the catalytic subunit of protein kinase CK2 |